Abstract

Multiple sclerosis (MS) is a chronic, immune-mediated, inflammatory, and degenerative disease of the central nervous system (CNS) that affects both white and gray matter. Various mechanisms throughout its course, mainly regarding gray matter lesions and brain atrophy, result in cognitive network dysfunction and can cause clinically significant cognitive impairment in roughly half the persons living with MS. Altered cognition is responsible for many negative aspects of patients' lives, independently of physical disability, such as higher unemployment and divorce rates, reduced social activities, and an overall decrease in quality of life. Despite its devastating impact it is not included in clinical ratings and decision making in the way it should be. It is interesting that only half the persons with MS exhibit cognitive dysfunction, as this implies that the other half remain cognitively intact. It appears that a dynamic balance between brain destruction and brain reorganization is taking place. This balance acts in favor of keeping brain systems functioning effectively, but this is not so in all cases, and the effect does not last forever. When these systems collapse, functional brain reorganization is not effective anymore, and clinically apparent impairments are evident. It is therefore important to reveal which factors could make provision for the subpopulation of patients in whom cognitive impairment occurs. Even if we manage to detect this subpopulation earlier, effective pharmaceutical treatments will still be lacking. Nevertheless, recent evidence shows that cognitive rehabilitation and neuromodulation, using non-invasive techniques such as transcranial magnetic or direct current stimulation, could be effective in cognitively impaired patients with MS. In this Mini Review, we discuss the mechanisms underlying cognitive impairment in MS. We also focus on mechanisms of reorganization of cognitive networks, which occur throughout the disease course. Finally, we review theoretical and practical issues of neurorehabilitation and neuromodulation for cognition in MS as well as factors that influence them and prevent them from being widely applied in clinical settings.

Highlights

  • People living with Multiple sclerosis commonly exhibit cognitive deficits, which negatively affects them multidimensionally [1]

  • The disease does not last only 20 years, but it is lifelong; the mean age of People living with Multiple sclerosis (pwMS) in this study was noted as 49.3 years, meaning that the majority of them will still be alive 10– 20 years later, the proportion of disabled will definitely increase, as will co-morbidities [82], and their treatment opportunities will be narrowed

  • What we have undoubtedly learned is that Cognitive impairment (CI) at diagnosis predicts worse future disease progression [85], impairment of specific cognitive sub-domains might better predict progression [86], and patients with pediatric onset Multiple sclerosis (MS) are more likely to have CI than patients with disease onset in adulthood, independent of age, or disease duration [87]

Read more

Summary

INTRODUCTION

People living with Multiple sclerosis (pwMS) commonly exhibit cognitive deficits, which negatively affects them multidimensionally [1]. Social cognitive deficits are an underestimated but important aspect of impairment in MS, reflecting how people process, store, and apply information in social interactions Deficits in these domains have been associated with reduced quality of life, even after controlling for severity and duration of the disease, age, and neurocognitive performance [22, 23]. Functional connectivity (FC) at rest and during tasks can detect both hyperconnectivity and hypoconnectivity in brain networks This can compensate for tissue damage, allowing pwMS to adequately cope with everyday cognitive tasks despite continuing structural brain damage. The study reported that the strengthening of local network properties was only detectable in the cortex of patients and occurred independently of their disease activity Authors discuss these changes as an adaptive mechanism that is important for maintaining brain function in response to neuroinflammation. Network efficiency is challenged by tissue damage, restorative mechanisms become inadequate, and, the network collapses [18]

Regional Tissue Damage and Atrophy
Synaptopathy in MS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.